IPP Bureau
Ajanta Pharma Q1FY22 consolidated net profit up at Rs. 173.75 Cr
By IPP Bureau - August 01, 2021
It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.
Unichem Laboratories Q1FY22 consolidated loss at Rs. 11.48 Cr
By IPP Bureau - August 01, 2021
The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.
Zydus Cadila receives approval from USFDA for Fulvestrant Injection
By IPP Bureau - July 31, 2021
The group now has 320 approvals and has so far filed over 400 ANDAs
Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr
By IPP Bureau - July 31, 2021
It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.
Zydus Wellness Q1FY22 consolidated net profit at Rs. 130.80 Cr
By IPP Bureau - July 31, 2021
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
Eris Lifesciences planning new manufacturing facility
By IPP Bureau - July 30, 2021
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
RPG Life Sciences Q1FY22 PAT surges to Rs. 13.58 Cr
By IPP Bureau - July 29, 2021
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
Astec Lifesciences 1FY22 consolidated PAT at Rs. 12.98 Cr
By IPP Bureau - July 29, 2021
The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.
Pfizer posts Q1FY22 PAT of Rs. 199.91 Cr
By IPP Bureau - July 29, 2021
The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.
Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
By IPP Bureau - July 28, 2021
The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.
Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr
By IPP Bureau - July 28, 2021
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr
By IPP Bureau - July 28, 2021
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
